GetTopicDetailResponse(id=a05c30224f, topicName=Avadomide, introduction=Avadomide, content=null, image=null, comments=3, allHits=1052, url=https://h5.medsci.cn/topic?id=3022, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=85761, tagList=[TagDto(tagId=85761, tagName=Avadomide)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1631309, encodeId=679c163130913, content=<a href='/topic/show?id=a05c30224f' target=_blank style='color:#2F92EE;'>#Avadomide#</a>, objectTitle=Lancet Haematol：Avadomide聯合obinutuzumab治療復發(fā)性或難治性非霍奇金淋巴瘤, objectType=article, longId=198711, objectId=97c8198e11f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97c8198e11f4, replyNumber=0, likeNumber=111, createdTime=2020-08-06, rootId=0, userName=linne327, userId=e44221706814, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97c8198e11f4, moduleTitle=Lancet Haematol：Avadomide聯合obinutuzumab治療復發(fā)性或難治性非霍奇金淋巴瘤, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=97c8198e11f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1631308, encodeId=e11a163130886, content=<a href='/topic/show?id=a05c30224f' target=_blank style='color:#2F92EE;'>#Avadomide#</a>, objectTitle=Blood：Avadomide(CC-122)單藥治療難治性/復發(fā)性DLBCL的療效和安全性, objectType=article, longId=187353, objectId=19ef18e35330, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=19ef18e35330, replyNumber=0, likeNumber=71, createdTime=2020-02-05, rootId=0, userName=linne327, userId=e44221706814, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=19ef18e35330, moduleTitle=Blood：Avadomide(CC-122)單藥治療難治性/復發(fā)性DLBCL的療效和安全性, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=19ef18e35330)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1631307, encodeId=6be1163130eda, content=<a href='/topic/show?id=a05c30224f' target=_blank style='color:#2F92EE;'>#Avadomide#</a>, objectTitle=CLIN CANCER RES：Avadomide治療晚期惡性腫瘤, objectType=article, longId=158549, objectId=2594158549cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2594158549cd, replyNumber=0, likeNumber=80, createdTime=2019-01-22, rootId=0, userName=linne327, userId=e44221706814, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2594158549cd, moduleTitle=CLIN CANCER RES：Avadomide治療晚期惡性腫瘤, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=2594158549cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
